A New Implantable Closed-Loop Clinical Neural Interface: First Application in Parkinson's Disease

Area of Science:

• Biomedical Engineering
• Neuroscience
• Medical Devices

Background:

• Deep brain stimulation (DBS) is a key treatment for movement disorders such as Parkinson's disease, dystonia, and essential tremor.
• Improving DBS efficacy requires continuous monitoring of stimulation effects on patient symptoms and neurophysiological markers.
• Conventional DBS devices need to evolve into bidirectional interfaces capable of neural signal recording, processing, storage, and wireless communication.

Purpose of the Study:

• To present the architecture, design, and initial use of an implantable stimulation and sensing interface (AlphaDBS System).
• To demonstrate a clinically viable implantable brain-computer interface (BCI) for adaptive DBS.
• To validate artifact-free neural recordings and robust data management for chronic use.

Main Methods:

• Development of the AlphaDBS System, an implantable bidirectional interface for stimulation and neural sensing.
• Implementation of artifact-free recording and distributed data management protocols.
• Clinical trial (NCT04681534) involving three Parkinson's disease patients to test the system's functionality.

Main Results:

• The AlphaDBS System demonstrated artifact-free neural recordings in Parkinson's disease patients.
• The system successfully managed chronic long-term neural data and signals.
• The study confirmed the system's viability as a brain-computer interface for adaptive DBS.

Conclusions:

• The AlphaDBS System represents a significant advancement in DBS technology, enabling bidirectional communication.
• The system's artifact-free recording and data management capabilities are crucial for adaptive DBS.
• This technology paves the way for more personalized and effective treatments for neurological disorders.